Refine by
Clinical Trial Articles & Analysis: This-Year
18 articles found
Many oncology drugs have been abandoned by pharmaceutical companies due to poor performance in phase I, II, or III clinical trials. These drugs represent untapped potential treatments for indications outside of those initially investigated. With research and development costs for a single new drug estimated between $2–3 billion, abandoned drugs represent ...
This collaborative approach accelerates the path from lab bench to clinical trials. Conclusion The CHO cell antibody drug production service represents a vital component of the biopharmaceutical landscape. ...
This profiling can reveal the context-dependent effects of inhibitors and identify biomarkers for patient stratification in clinical trials. By understanding the kinase landscape within specific tumors, researchers can tailor treatments to enhance efficacy and reduce toxicity. ...
These findings suggest potential avenues for therapeutic intervention targeting neuroinflammation. However, the clinical translation of chemokine-based therapies is fraught with challenges. ...
The Evolution of Antibody Drug Design Traditional methods of drug development often involved trial-and-error approaches to identify suitable candidates. However, with advancements in biotechnology and biochemistry, the design of antibody-based therapies has undergone a paradigm shift. ...
The main focus of drug carrier research today is to identify carriers that are both safe and effective for clinical treatment applications. As treatment strategies advance researchers regularly update drug delivery systems. Traditional drug delivery systems consist of liposomes and polymer micelles together with nanoparticles but despite their inclusion in ...
Millions of people are affected by sleep apnea that is a sleep disorder, characterized by disrupted breathing when asleep. Sleep apnea leads to cardiovascular issues, chronic fatigue, daytime drowsiness and poor cognitive functioning. Additionally, the sleep deprivation that sets in with time leads to irritability and mood swings, affecting your day-to-day functioning and quality of life. ...
By analyzing the metabolic pathway in S9 assays, researchers can pinpoint these toxic metabolites early in the drug development process, potentially saving time and resources by avoiding compounds that may fail later in clinical trials. In addition to these practical applications, S9 metabolic stability assessments contribute to enhancing the overall ...
In Vitro and In Vivo Studies: Prior to human trials, extensive laboratory studies are conducted to evaluate the efficacy, stability, and safety of the conjugate. ...
Ensuring compliance with safety and efficacy standards set by health authorities necessitates rigorous clinical trials and extensive documentation. Future Prospects Looking ahead, the future of recombinant vaccine production appears promising. ...
It is the process that bridges the gap between basic research and clinical testing, allowing for the evaluation of potential drug candidates in biological systems before they are tested in humans. ...
This information helps healthcare professionals design a customized treatment plan tailored to the individual’s specific needs. Clinical Trials: Many immuno-oncology services offer access to cutting-edge clinical trials. These trials provide patients with opportunities to participate in research aimed at ...
The quest for effective therapeutics begins long before a drug reaches clinical trials. One of the cornerstones of this process is drug screening in animal models, which plays a pivotal role in evaluating the safety and efficacy of potential treatments. ...
It works as a dual SGLT1 and SGLT2 inhibitor, helping to regulate blood sugar levels while also protecting the heart. Clinical trials demonstrated a 23% reduction in cardiovascular-related deaths and events among patients taking this medication. ...
Precise NAD/NADH measurement is indispensable for evaluating the efficacy and mechanisms of these therapeutics in preclinical and clinical trials. Techniques for NAD/NADH Analysis Accurate analysis of NAD/NADH is challenging due to their instability and low abundances in biological samples. ...
These markers help in the identification and isolation of hMSCs for research and clinical applications. Another defining feature of hMSCs is their immunomodulatory properties. ...
But there are also a lot of problems in the clinical use of NPs. NPs, for instance, once inserted into the body will be assessed and excised by the body's innards as foreign substances that generate immune responses and toxic effects. ...
These assessments continuously evolve, aiming to mitigate the incidence of cardiovascular toxicity that may emerge during clinical trials. To shed light on the intricate dynamics of cardiovascular toxicity, let’s examine the case of two distinct small-molecule inhibitors, Compound A and Compound B, described in a recent study1 by Yevgeniya E. ...